First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration
Clinical trial NCT04246866 · COMPLETED
Trial details
- NCT number
- NCT04246866
- Sponsor
- Gemini Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-19
- Primary completion
- 2020-10-21
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.